Matinas BioPharma Holdings, Inc.
MTNB · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $5 | $7 | $21 |
| Short-Term Investments | $0 | $9 | $22 | $29 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $2 | $6 | $1 |
| Total Curr. Assets | $8 | $16 | $35 | $51 |
| Property Plant & Equip (Net) | $2 | $5 | $6 | $6 |
| Goodwill | $0 | $1 | $1 | $1 |
| Intangibles | $2 | $3 | $3 | $3 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $34 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $5 | $10 | $44 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $13 | $25 | $79 | $61 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1 | $1 | $1 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $0 |
| Other Curr. Liab. | $2 | $1 | $2 | $3 |
| Total Curr. Liab. | $3 | $3 | $4 | $4 |
| LT Debt | $2 | $3 | $4 | $4 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $34 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $3 | $38 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $4 | $4 | $5 |
| Total Liabilities | $5 | $6 | $42 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$200 | -$176 | -$153 | -$132 |
| AOCI | $0 | -$0 | -$1 | -$0 |
| Other Equity | $207 | $195 | $190 | $184 |
| Total Equity | $8 | $19 | $37 | $52 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $13 | $25 | $79 | $61 |
| Net Debt | -$4 | -$1 | -$3 | -$16 |